Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05038553 · ClinicalTrials.gov registry record
Chronic Pain in Rheumatoid Arthritis
A clinical trial of Pain and Arthritis, Rheumatoid, sponsored by Northwestern University.
- Recruiting
- Registry status
- 125
- Enrollment target
- 5
- Study locations
NCT05038553: Recruiting study of Pain and Arthritis, Rheumatoid, sponsored by Northwestern University.
NCT05038553 is a study of Pain and Arthritis, Rheumatoid that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 125 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (59% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05038553, a study of Pain and Arthritis, Rheumatoid, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective is to identify modifiable clinical factors and neurobiological pathways that lead to the development of chronic pain in patients with early rheumatoid arthritis. Participants will undergo quantitative sensory testing, a type of testing that involves assessing response to well-defined, quantifiable painful stimuli, at 0, 3, and 12 months. A subset of participants will also undergo magnetic resonance imaging at 0 and 12 months to assess neuroimaging markers that have previously been shown to be involved in chronic pain.
Primary Outcome
Minimum value 0, maximum value 31; higher scores indicate worse outcomes
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (5)
Colorado
- University of Colorado - Denver
Illinois
- Northwestern University - Chicago
Maryland
- Johns Hopkins University - Baltimore
Michigan
- University of Michigan - Ann Arbor
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2026-04-30 |
What NCT05038553 shows while recruiting
NCT05038553 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT05038553 lists 5 locations in 5 states (Colorado, Illinois, Maryland).
Frequently Asked Questions
What is clinical trial NCT05038553 about?
NCT05038553 is a clinical study titled "Chronic Pain in Rheumatoid Arthritis". The objective is to identify modifiable clinical factors and neurobiological pathways that lead to the development of chronic pain in patients with early rheumatoid arthritis. Participants will undergo quantitative sensory testing, a type of testing that involves assessing response to well-defined, ...
What is the current status of trial NCT05038553?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2021-10-12. Estimated completion is 2026-04-30.
What conditions does trial NCT05038553 study?
This clinical trial studies the following conditions: Pain, Arthritis, Rheumatoid.
What interventions are being tested in trial NCT05038553?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05038553?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05038553 being conducted?
This trial has 5 study locations across Colorado, Illinois, Maryland, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05038553's enrollment target sits among peer trials
125 130th of 374 higher than 243 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI